Literature DB >> 16250255

A comparison of glutathione S-transferase mutant frequencies in healthy Han and Uygur Chinese.

Shi-Long Zhong1, Shufeng Zhou, Min Huang.   

Abstract

OBJECTIVE: This study was to compare the frequencies of genetic polymorphisms of GSTM1, GSTT1, and GSTP1 in Uygur Chinese with those in Han Chinese.
METHODS: GSTM1 and GSTT1 polymorphisms were analyzed by a PCR-Multiplex procedure, whereas GSTP1 polymorphism was analyzed by PCR-RFLP.
RESULTS: The frequency of GSTM1 null genotype in Han Chinese (56.1%) was similar to that in Uygur Chinese (53.2%) (P = 0.592), whilst the frequency of GSTT1 null genotype in Han Chinese (50.0%) was significantly (P < 0.05) higher than that of Uygur Chinese (26.6%). GSTP1 had a genotype distribution of 60.7% I/I, 35.2% I/V and 4.1% V/V in Han Chinese, and 51.3% I/I, 40.2% I/V and 8.4% V/V in Uygur Chinese.
CONCLUSION: There is marked ethnic difference in the mutant frequencies of GSTT1 and GSTP1, but not GSTM1, between Uygur and Han Chinese.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16250255     DOI: 10.1007/BF03190618

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  45 in total

1.  Hereditary differences in the expression of the human glutathione transferase active on trans-stilbene oxide are due to a gene deletion.

Authors:  J Seidegård; W R Vorachek; R W Pero; W R Pearson
Journal:  Proc Natl Acad Sci U S A       Date:  1988-10       Impact factor: 11.205

2.  Glutathione S-transferase mu locus: use of genotyping and phenotyping assays to assess association with lung cancer susceptibility.

Authors:  S Zhong; A F Howie; B Ketterer; J Taylor; J D Hayes; G J Beckett; C G Wathen; C R Wolf; N K Spurr
Journal:  Carcinogenesis       Date:  1991-09       Impact factor: 4.944

3.  Frequency of mutant CYPIA1, NAT2 and GSTM1 alleles in a normal Chinese population.

Authors:  E J Lee; B Zhao; S M Moochhala; S S Ngoi
Journal:  Pharmacogenetics       Date:  1994-12

4.  Gene deficiency of glutathione S-transferase mu isoform associated with susceptibility to lung cancer in a Chinese population.

Authors:  G F Sun; N Shimojo; J B Pi; S Lee; Y Kumagai
Journal:  Cancer Lett       Date:  1997-02-26       Impact factor: 8.679

5.  Polymorphisms within glutathione S-transferase genes (GSTM1, GSTT1, GSTP1) and risk of relapse in childhood B-cell precursor acute lymphoblastic leukemia: a case-control study.

Authors:  M Stanulla; M Schrappe; A M Brechlin; M Zimmermann; K Welte
Journal:  Blood       Date:  2000-02-15       Impact factor: 22.113

6.  Polymorphisms in glutathione S-transferases (GSTM1 and GSTT1) and survival after treatment for breast cancer.

Authors:  C B Ambrosone; C Sweeney; B F Coles; P A Thompson; G Y McClure; S Korourian; M Y Fares; A Stone; F F Kadlubar; L F Hutchins
Journal:  Cancer Res       Date:  2001-10-01       Impact factor: 12.701

7.  Human glutathione S-transferase theta (GSTT1): cDNA cloning and the characterization of a genetic polymorphism.

Authors:  S Pemble; K R Schroeder; S R Spencer; D J Meyer; E Hallier; H M Bolt; B Ketterer; J B Taylor
Journal:  Biochem J       Date:  1994-05-15       Impact factor: 3.857

8.  Genetic polymorphisms in GSTM1, GSTP1, and GSTT1 and the risk for breast cancer: results from the Shanghai Breast Cancer Study and meta-analysis.

Authors:  Kathleen M Egan; Qiuyin Cai; Xiao-Ou Shu; Fan Jin; Tian-Li Zhu; Qi Dai; Yu-Tang Gao; Wei Zheng
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2004-02       Impact factor: 4.254

9.  Human genes for glutathione S-transferases.

Authors:  V Laisney; M S Gross; J Frezal
Journal:  Hum Genet       Date:  1984       Impact factor: 4.132

10.  Ethnicity and glutathione S-transferase (GSTM1/GSTT1) polymorphisms in a Brazilian population.

Authors:  G J F Gattás; M Kato; J A Soares-Vieira; M S Siraque; P Kohler; L Gomes; M A V Rego; S P Bydlowski
Journal:  Braz J Med Biol Res       Date:  2004-03-23       Impact factor: 2.590

View more
  1 in total

1.  Genetic markers in CYP2C19 and CYP2B6 for prediction of cyclophosphamide's 4-hydroxylation, efficacy and side effects in Chinese patients with systemic lupus erythematosus.

Authors:  Wenying Shu; Su Guan; Xiuyan Yang; Liuqin Liang; Jiali Li; Zhuojia Chen; Yu Zhang; Lingyan Chen; Xueding Wang; Min Huang
Journal:  Br J Clin Pharmacol       Date:  2015-12-25       Impact factor: 4.335

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.